
Keywords: 5-HT; 5-hydroxytryptamine, serotonin; vortioxetine; 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004); LTP; long-term potentiation; SR57227; 1-(6-chloro-2-pyridinyl)-4-piperidinamine; MDD; major depressive disorder; SERT; 5-HT transporter; f